NYTIMES (Gina Kolata) - A Promising Heart Drug Failed. What Went So Wrong?
Cardiologists are struggling to figure out why a drug that should have prevented heart attacks didn’t work at all.
NYTIMES (Gina Kolata) - The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
AXIOS (Adriel Bettelheim) - AI giants lean into health care to stall public backlash
AI has an image problem . And one way to fix it is for top companies to dive headlong into health care. Why it matters: Saving the world with AI-designed cures is better than being blamed for ruining the environment or driving up Americans' utility bills. - But even the most advanced AI models can't produce miracle treatments at the moment — and could create serious security risks if they try. - That could set up a fraught debate over the next two or three years about the allocation of resources and whether the benefits of throwing vast amounts of computing capacity into medical research outweigh the costs. Driving the news: The Wall Street Journal reported this month that Anthropic was trying to shore up investor confidence ahead…
NYTIMES (Michael Levenson) - Henrietta Lacks’s Family Settles Suit With Novartis Over Use of Her Cells
Ms. Lacks’s family accused Novartis of profiting from her cells, which were taken from her without her consent in 1951, when she was dying of cervical cancer.